Nanotechnology: Scientific promise meets business perils
By Anette Breindl
Wednesday, April 9, 2014
SAN DIEGO At a session on Application of Nanotechnology to the Treatment of Cancer Patients, the presenters showed multiple ways in which nanotechnology could improve cancer treatment and diagnostics. If, that is, the technology can make it onto pharma's priority list. Moderator Mark Davis kicked off the session by pointing out that the idea of nanoparticles itself is not new. But scientific advances have increased the understanding of multiple different functions nanoparticles can have to optimize drug delivery. "Now people know how to make these multiple functions work together properly," he told the audience, citing the example of Bind Biosciences Inc.'s BIND-014, which has optimized multiple functions simultaneously.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.